| Literature DB >> 27294258 |
Z Irene Wang1, P Suwanpakdee2, S E Jones3, Z Jaisani4, Ahsan N V Moosa5, I M Najm5, F von Podewils6, R C Burgess5, B Krishnan5, R A Prayson7, J A Gonzalez-Martinez8, W Bingaman8, A V Alexopoulos5.
Abstract
Management of MRI-negative patients with intractable focal epilepsy after failed surgery is particularly challenging. In this study, we aim to investigate whether MRI post-processing could identify relevant targets for the re-evaluation of MRI-negative patients who failed the initial resective surgery. We examined a consecutive series of 56 MRI-negative patients who underwent resective surgery and had recurring seizures at 1-year follow-up. T1-weighted volumetric sequence from the pre-surgical MRI was used for voxel-based MRI post-processing which was implemented in a morphometric analysis program (MAP). MAP was positive in 15 of the 56 patients included in this study. In 5 patients, the MAP+ regions were fully resected. In 10 patients, the MAP+ regions were not or partially resected: two out of the 10 patients had a second surgery including the unresected MAP+ region, and both became seizure-free; the remaining 8 patients did not undergo further surgery, but the unresected MAP+ regions were concordant with more than one noninvasive modality in 7. In the 8 patients who had unresected MAP+ regions and intracranial-EEG before the previous surgery, the unresected MAP+ regions were concordant with ictal onset in 6. Our data suggest that scrutiny of the presurgical MRI guided by MRI post-processing may reveal relevant targets for reoperation in nonlesional epilepsies. MAP findings, when concordant with the patient's other noninvasive data, should be considered when planning invasive evaluation/reoperation for this most challenging group of patients.Entities:
Keywords: Epilepsy; Failed surgery; Focal cortical dysplasia; MRI-negative; Presurgical evaluation; Voxel-based morphometry
Mesh:
Year: 2016 PMID: 27294258 PMCID: PMC5011447 DOI: 10.1007/s00415-016-8171-7
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849